NasdaqCM - Delayed Quote USD

Inotiv, Inc. (NOTV)

4.0500 -0.2400 (-5.59%)
At close: April 26 at 4:00 PM EDT
4.0500 0.00 (0.00%)
After hours: April 26 at 6:10 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
Total Revenue
585,172.0000
572,425.0000
547,656.0000
89,605.0000
60,469.0000
Cost of Revenue
411,746.0000
406,982.0000
390,444.0000
59,449.0000
42,232.0000
Gross Profit
173,426.0000
165,443.0000
157,212.0000
30,156.0000
18,237.0000
Operating Expense
167,971.0000
174,683.0000
136,961.0000
30,397.0000
21,300.0000
Operating Income
5,455.0000
-9,240.0000
20,251.0000
-241.0000
-3,063.0000
Net Non Operating Interest Income Expense
-43,933.0000
-43,019.0000
-29,704.0000
-1,683.0000
-1,490.0000
Other Income Expense
-2,180.0000
-71,983.0000
-342,996.0000
8,043.0000
15.0000
Pretax Income
-40,658.0000
-124,242.0000
-352,449.0000
6,119.0000
-4,538.0000
Tax Provision
-31,820.0000
-19,340.0000
-15,187.0000
-4,776.0000
147.0000
Net Income Common Stockholders
-33,205.0000
-105,140.0000
-337,018.0000
10,895.0000
-4,685.0000
Average Dilution Earnings
--
--
--
-8,322.0000
--
Diluted NI Available to Com Stockholders
-33,205.0000
-105,140.0000
-337,018.0000
10,895.0000
-4,685.0000
Basic EPS
-1.29
-4.10
-13.84
0.83
-0.43
Diluted EPS
-1.29
-4.10
-13.84
0.19
-0.43
Basic Average Shares
25,681.2500
25,641.0000
24,354.0000
13,191.0000
10,851.0000
Diluted Average Shares
25,681.2500
25,641.0000
24,354.0000
13,865.0000
10,851.0000
Total Operating Income as Reported
-253.0000
-81,460.0000
-263,452.0000
-5,618.0000
-3,063.0000
Total Expenses
579,717.0000
581,665.0000
527,405.0000
89,846.0000
63,532.0000
Net Income from Continuing & Discontinued Operation
-33,205.0000
-105,140.0000
-337,018.0000
10,895.0000
-4,685.0000
Normalized Income
-28,695.6800
-44,186.3200
-65,514.2290
14,820.2100
-4,685.0000
Interest Expense
43,933.0000
43,019.0000
29,704.0000
1,683.0000
1,490.0000
Net Interest Income
-43,933.0000
-43,019.0000
-29,704.0000
-1,683.0000
-1,490.0000
EBIT
3,275.0000
-81,223.0000
-322,745.0000
7,802.0000
-3,048.0000
EBITDA
58,979.0000
-26,506.0000
-273,421.0000
14,070.0000
1,026.0000
Reconciled Cost of Revenue
391,710.0000
386,946.0000
372,008.0000
54,949.0000
42,232.0000
Reconciled Depreciation
55,704.0000
54,717.0000
49,324.0000
6,268.0000
4,074.0000
Net Income from Continuing Operation Net Minority Interest
-33,205.0000
-105,140.0000
-337,018.0000
10,895.0000
-4,685.0000
Total Unusual Items Excluding Goodwill
-5,708.0000
-72,220.0000
-283,703.0000
-5,377.0000
--
Total Unusual Items
-5,708.0000
-72,220.0000
-283,703.0000
-5,377.0000
--
Normalized EBITDA
64,687.0000
45,714.0000
10,282.0000
19,447.0000
1,026.0000
Tax Rate for Calcs
0.0002
0.0002
0.0000
0.0003
0.0003
Tax Effect of Unusual Items
-1,198.6800
-11,266.3200
-12,199.2290
-1,451.7900
--
9/30/2020 - 11/25/1997

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CRL Charles River Laboratories International, Inc.
229.03
+0.54%
 
NEO NeoGenomics, Inc.
14.14
+2.09%
 
ISPC iSpecimen Inc.
0.2660
-5.07%
 
DRIO DarioHealth Corp.
1.4800
+2.07%
 
ACRS Aclaris Therapeutics, Inc.
1.2000
+0.84%
 
DIGP Hypha Labs, Inc.
0.0314
-4.47%
 
CORBF Global Cord Blood Corporation
1.2500
0.00%
 
IMMNOV.ST Immunovia AB (publ)
2.0550
+2.75%
 
BDSX Biodesix, Inc.
1.2350
-1.98%
 
CNTG Centogene N.V.
0.4889
+1.88%